REFERENCES
- Bernstein D, Tripodi J. Fulminant hepatic failure. Crit Care Clin. 1998;14:181–197.
- Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986;6:97–106.
- Bernal W, Wendon J. Acute liver failure: clinical features and management. Eur J Gastroenterol Hepatol. 1999;11:977–984.
- Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med. 2006;34(2):337–343.
- Parekh NK, Hynan LS, De Lemos J, Acute Liver Failure Study Group. Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Hepatology 2007;45:1489–1495.
- Papoutsidakis N, Arkadopoulos N, Smyrniotis V, Early myocardial injury is an integral component of experimental acute liver failure—a study in two porcine models. Arch Med Sci. 2011;7:217–223.
- Mann JM, Pierre-Louis M, Kragel PJ, Cardiac consequences of massive acetaminophen overdose. Am J Cardiol. 1989;63(13):1018–1021.
- Armour A, Slater SD. Paracetamol cardiotoxicity. Postgrad Med J. 1993;69(807):52–54.
- Bhagavan NV, Goldstein AP, Honda SAA, Role of cardiac troponin I in the evaluation of myocardial injury. J Clin Lab Anal. 1998;12:276–279.
- Adams JE, Bodor GS, Davila-Roman VG, Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993;88:101–106.
- Bodor GS, Porterfield D, Voss EM, Cardiac troponin-I not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem. 1995;41:1710–1715.
- Mangano DT, Beyond CK-Mb. Biochemical markers for perioperative myocardial infarction. Anesthesiology 1994;81:1317–1320.
- Collins JN, Cole FJ, Weireter LJ, Riblet JL, The usefulness of serum troponin levels in evaluating cardiac injury. Am Surg. 2001;67(9):821–825.
- Zaninotto M, Altinier S, Lachin M, Fluoroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction. Clin Chem. 1996;42(9):1460–1466.
- Collinson PO, Stubbs PJ. Are troponins confusing? Heart 2003;89:1285–1287.
- Hamm CW, Giannitsis E, Katus HA. Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 2002;106:2871–2872.
- Harrison PM, Wendon JA, Gimson AES, Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 1991;324:1852–1857.
- Amman P, Maggiorini M, Bertel O, Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol. 2003;41(11):2004–2009.
- Hiroko I, Masahito N, Tomoo N, Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med. 1998;26(5):873–876.
- Wu Z, Han M, Chen T, Acute liver failure: mechanisms of immune-mediated liver injury. Liver Int. 2010;30(6):782–794.
- Hoofnagle JH, Carithers RL, Shapiro C, Fulminant hepatic failure: summary of a workshop. Hepatology 1995;21:240–252.
- Makwana N, Baines PB. Myocardial dysfunction in meningococcal septic shock. Curr Opin Crit Care 2005;11:418–423.
- Liu H, Lee S. Acute on chronic liver failure: the heart and systemic hemodynamics. Curr Opin Crit Care 2011;17(2):190–194.
- Pateron D, Beyne P, Laperche T, Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology 1999;29(3):640–643.
- Theodoraki K, Kostopanagiotou G, Smyrniotis V, Haemodynamic changes in ischaemic vs. anhejpatic pig experimental model of acute liver failure. Eur J Anaesthesiol. 2002;19:40–46.
- Ostapowicz g, Fontana R, Schiodt F, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–954.
- Tunon MJ, Alvarez M, Culebras J, An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol. 2009;15(25):3086–3098.